학술논문
Efficacy and Safety of Brigatinib Compared With Crizotinib in Asian vs. Non-Asian Patients With Locally Advanced or Metastatic ALK–Inhibitor-Naive ALK+ Non–Small Cell Lung Cancer: Final Results From the Phase III ALTA-1L Study
Document Type
Article
Author
Ahn, Myung J.; Kim, Hye R.; Yang, James C.H.; Han, Ji-Yu; Li, Jacky Yu-Chung.; Hochmair, Maximilian J.; Chang, Gee-Chen; Delmonte, Angelo; Lee, Ki H.; Campelo, Rosario G.; Gridelli, Cesare; Spira, Alexander I.; Califano, Raffaele; Griesinger, Frank; Ghosh, Sharmistha; Felip, Enriqueta; Kim, Dong-Wan; Liu, Yuyin; Zhang, Pingkuan; Popat, Sanjay; Camidge, D. Ross
Source
In Clinical Lung Cancer December 2022 23(8):720-730
Subject
Language
ISSN
1525-7304